In fact, patients treated with placebo had a rate of flare-ups in autumn (7
In fact, patients treated with placebo had a rate of flare-ups in autumn (7.2%) and winter (8.4%) twice higher, in spring Rabbit Polyclonal to ZNF460 (4.6%) about 1.5 times higher than the one observed during summer (2.9%). to the non-asthmatic populace. Omalizumab, an anti-IgE monoclonal antibody, exerts a profound cellular effect, which can stabilize the…
Read More “In fact, patients treated with placebo had a rate of flare-ups in autumn (7” »